Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As 2O 3 and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR

European Journal of Pharmaceutical Sciences

Volumn 45, Issue 3, 2012, Pages 367-378

  Ong, Pei Shi ^a   Chan, Sui Yung ^a   Ho, Paul C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Arsenic trioxide; Chemoresistance; Gene expression; Microarray; Ovarian cancer

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; CISPLATIN; COMPLEMENTARY DNA; INTERLEUKIN 1ALPHA; PACLITAXEL; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CHEMORESISTANCE; CYTOTOXICITY; DNA MICROARRAY; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION PROFILING; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CELL CYCLE; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-1ALPHA; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; OXIDES; PACLITAXEL;

EID: 84855807757     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.12.003     Document Type: Article

References (87)

1. V. Almendro, E. Ametller, S. García-Recio, O. Collazo, I. Casas, J.M. Augé, J. Maurel, and P. Gascón The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin PLoS One 4 2009 E4728
2. Y. An, L. Cai, Y. Wang, D. Zhu, Y. Guan, and J. Zheng Local expression of insulin-like growth factor-I, insulin-like growth factor-I receptor, and estrogen receptor alpha in ovarian cancer Onkologie 32 2009 638 644
3. J.M. Arnold, P.R. Huggard, M. Cummings, G.A. Ramm, and G. Chenevix-Trench Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma Br. J. Cancer 92 2005 2024 2031 (Pubitemid 40897425)
4. K. Arai, S. Takano, T. Teratani, Y. Ito, T. Yamada, and R. Nozawa S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast Curr. Cancer Drug Targets 8 2008 243 252 (Pubitemid 351881350)
5. N. Askar, T. Cirpan, E. Toprak, B. Karabulut, N. Selvi, M.C. Terek, R. Uslu, U.A. Sanli, and E. Goker Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity Int. J. Gynecol. Cancer 16 2006 1552 1556 (Pubitemid 44060378)
6. P.E. Auron The interleukin 1 receptor: ligand interactions and signal transduction Cytokine Growth Factor Rev. 9 1998 221 237 (Pubitemid 29019708)
7. R. Baserga The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55 1995 249 252
8. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate - a practical and powerful approach to multiple testing J. R. Statist. Soc. B 57 1995 289 300
9. B.M. Bolstad, R.A. Irizarry, M. Astrand, and T.P. Speed A comparison of normalization methods for high density oligonucleotide array data based on bias and variance Bioinformatics 19 2003 185 193 (Pubitemid 36181903)
10. C.A. Borgoño, I.P. Michael, and E.P. Diamandis Human tissue kallikreins: physiologic roles and applications in cancer Mol. Cancer Res. 2 2004 257 280 (Pubitemid 39031076)
11. P. Carmeliet, L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J.J. van den Oord, D. Collen, and R.C. Mulligan Physiological consequences of loss of plasminogen activator gene function in mice Nature 368 1994 419 424 (Pubitemid 24115347)
12. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins Blood 88 1996 1052 1061 (Pubitemid 26333331)
13. J. Dai, R.S. Weinberg, S. Waxman, and Y. Jing Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system Blood 93 1999 268 277 (Pubitemid 29019412)
14. S.M. Deneke, and B.L. Fanburg Regulation of cellular glutathione Am. J. Physiol. 257 1989 L163 L173
15. M.S. DeRycke, J.D. Andersen, K.M. Harrington, S.E. Pambuccian, S.E. Kalloger, K.L. Boylan, P.A. Argenta, and A.P. Skubitz S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival Am. J. Clin. Pathol. 132 2009 846 856
16. C.A. Dinarello Interleukin-1, interleukin-1 receptors, and interleukin-1 receptor antagonist Int. Rev. Immunol. 16 1998 457 499
17. V.M. Díaz, J. Planaguma, T.M. Thomson, J. Reventós, and R. Paciucci Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells Gastroenterology 122 2002 806 819 (Pubitemid 34173834)
18. Y. Dong, O.L. Tan, D. Loessner, C. Stephens, C. Walpole, G.M. Boyle, P.G. Parsons, and J.A. Clements Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma Cancer Res. 70 2010 2624 2633
19. M.G. Dozmorov, J.T. Azzarello, J.D. Wren, K.M. Fung, Q. Yang, J.S. Davis, R.E. Hurst, D.J. Culkin, T.M. Penning, and H.K. Lin Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression BMC Cancer 10 2010 672
20. Y.H. Du, and P.C. Ho Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines Cancer Chemother. Pharmacol. 47 2001 481 490 (Pubitemid 32477294)
21. M.J. Duffy The urokinase plasminogen activator system: role in malignancy Curr. Pharm. Des. 10 2004 39 49 (Pubitemid 38072742)
22. Y.J. Fang, Z.H. Lu, G.Q. Wang, Z.Z. Pan, Z.W. Zhou, J.P. Yun, M.F. Zhang, and D.S. Wan Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer Int. J. Colorectal Dis. 24 2009 875 884
23. J.S. Fitzgerald, S.A. Tsareva, T.G. Poehlmann, L. Berod, A. Meissner, F.M. Corvinus, B. Wiederanders, E. Pfitzner, U.R. Markert, and K. Friedrich Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells Int. J. Biochem. Cell Biol. 37 2005 2284 2296 (Pubitemid 41207401)
24. R. Gallego, J. Codony-Servat, X. García-Albéniz, E. Carcereny, R. Longarón, A. Oliveras, M. Tosca, J.M. Augé, P. Gascón, and J. Maurel Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer Endocr. Relat. Cancer 16 2009 311 317
25. C. Gialeli, A.D. Theocharis, and N.K. Karamanos Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting FEBS J. 278 2011 16 27
26. H. Guo, T. Tian, K. Nan, and W. Wang P57: a multifunctional protein in cancer Int. J. Oncol. 36 2010 1321 1329
27. A. Hermani, B. De Servi, S. Medunjanin, P.A. Tessier, and D. Mayer S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells Exp. Cell Res. 312 2006 184 197 (Pubitemid 41721180)
28. S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis Nat. Cell Biol. 8 2006 1369 1375 (Pubitemid 44835111)
29. M. Hurtado, J.J. Lozano, E. Castellanos, L.A. López- Fernández, K. Harshman, C. Martínez-A, A.R. Ortiz, T.M. Thomson, and R. Paciucci Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells Gut 56 2007 1266 1274 (Pubitemid 47300429)
30. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, and M. Yamamoto Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 13 1999 76 86 (Pubitemid 29045117)
31. A.K. Jansson, C. Gunnarsson, M. Cohen, T. Sivik, and O. Stl 17β-Hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor positive breast cancer Cancer Res. 66 2006 11471 11477 (Pubitemid 46009980)
32. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
33. N. Jessani, M. Humphrey, W.H. McDonald, S. Niessen, K. Masuda, B. Gangadharan, J.R. Yates 3rd., B.M. Mueller, and B.F. Cravatt Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo Proc. Natl. Acad. Sci. USA. 101 2004 13756 13761 (Pubitemid 39298480)
34. W. Ju, B.C. Yoo, I.J. Kim, J.W. Kim, S.C. Kim, and H.P. Lee Identification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarrays Oncol. Res. 18 2009 47 56
35. K.R. Kalli, and C.A. Conover The insulin-like growth factor/insulin system in epithelial ovarian cancer Front. Biosci. 8 2003 714 722
36. H. Kamohara, K. Sakamoto, T. Ishiko, Y. Masuda, T. Abe, and M. Ogawa Leukemia inhibitory factor induces apoptosis and proliferation of human carcinoma cells through different oncogene pathways Int. J. Cancer 72 1997 687 695 (Pubitemid 27356173)
37. H. Kamohara, M. Ogawa, T. Ishiko, K. Sakamoto, and H. Baba Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: involvement of regulation of LIF and its receptor expression Int. J. Oncol. 30 2007 977 983
38. H. Kawai, Y. Minamiya, and N. Takahashi Prognostic impact of S100A9 overexpression in non-small cell lung cancer Tumour Biol. 32 2011 641 646
39. P. Kellokumpu-Lehtinen, M. Talpaz, D. Harris, Q. Van, R. Kurzrock, and Z. Estrov Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways Int. J. Cancer 66 1996 515 519 (Pubitemid 26176769)
40. E.J. Kim, J.I. Park, and B.D. Nelkin IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells J. Biol. Chem. 280 2005 4913 4920 (Pubitemid 40288666)
41. B. Kong, S. Huang, W. Wang, D. Ma, X. Qu, J. Jiang, X. Yang, Y. Zhang, B. Wang, B. Cui, and Q. Yang Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines Int. J. Gynecol. Cancer 15 2005 872 877 (Pubitemid 41783095)
42. S. L'Espérance, I. Popa, M. Bachvarova, M. Plante, N. Patten, L. Wu, B. Têtu, and D. Bachvarov Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors Int. J. Oncol. 29 2006 5 24
43. D. LeRoith, and C.T. Roberts Jr. The insulin-like growth factor system and cancer Cancer Lett. 195 2003 127 137 (Pubitemid 36588961)
44. A.M. Lewis, S. Varghese, H. Xu, and H.R. Alexander Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment J. Transl. Med. 4 2006 48
45. Y.H. Ling, J.D. Jiang, J.F. Holland, and R. Perez-Soler Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines Mol. Pharmacol. 62 2002 529 538 (Pubitemid 36329371)
46. Q. Liu, H. Zhang, L. Smeester, F. Zou, M. Kesic, I. Jaspers, J. Pi, and R.C. Fry The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel BMC Med. Genomics 3 2010 37
47. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
48. B.M. Lomaestro, and M. Malone Glutathione in health and disease: pharmacotherapeutic issues Ann. Pharmacother. 29 1995 1263 1273 (Pubitemid 26044866)
49. M. Markman Pharmaceutical management of ovarian cancer: current status Drugs 68 2008 771 789 (Pubitemid 351550530)
50. M.U. Martin, and W. Falk The interleukin-1 receptor complex and interleukin-1 signal transduction Eur. Cytokine Netw. 8 1997 5 17 (Pubitemid 27189850)
51. S. Malki, F. Bibeau, C. Notarnicola, S. Roques, P. Berta, F. Poulat, and B. Boizet-Bonhoure Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells Cancer Lett. 255 2007 182 193 (Pubitemid 47268638)
52. K. Miura, H. Karasawa, and I. Sasaki CIAP2 as a therapeutic target in colorectal cancer and other malignancies Expert Opin. Ther. Targets 13 2009 1333 1345
53. K. Mujoo, L. Zhang, J. Klostergaard, and N.J. Donato Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacement Int. J. Gynecol. Cancer 10 2000 105 114 (Pubitemid 30351309)
54. Y. Nakagawa, S. Abe, M. Kurata, M. Hasegawa, K. Yamamoto, M. Inoue, T. Takemura, K. Suzuki, and M. Kitagawa IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes Am. J. Hematol. 81 2006 824 831 (Pubitemid 44682183)
55. A. Nikitin, S. Egorov, N. Daraselia, and I. Mazo Pathway studio - the analysis and navigation of molecular networks Bioinformatics 19 2003 2155 2157 (Pubitemid 37408171)
56. T. Nguyen, P.J. Sherratt, and C.B. Pickett Regulatory mechanisms controlling gene expression mediated by the antioxidant response element Annu. Rev. Pharmacol. Toxicol. 43 2003 233 260 (Pubitemid 37372641)
57. B.M. Nolen, and A.E. Lokshin Targeting CCL11 in the treatment of ovarian cancer Expert Opin. Ther. Targets 14 2010 157 167
58. O.O. Oduwole, Y. Li, V.V. Isomaa, A. Mäntyniemi, A.E. Pulkka, Y. Soini, and P.T. Vihko 17β-Hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer Cancer Res. 64 2004 7604 7609 (Pubitemid 39372106)
59. 3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation Int. J. Oncol. 38 2011 1731 1739
60. E. Ortiz-Zapater, S. Peiró, O. Roda, J.M. Corominas, S. Aguilar, C. Ampurdanés, F.X. Real, and P. Navarro Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2 Am. J. Pathol. 170 2007 1573 1584 (Pubitemid 47339302)
61. T. Passeron, J.C. Valencia, T. Namiki, W.D. Vieira, H. Passeron, Y. Miyamura, and V.J. Hearing Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid J. Clin. Invest. 119 2009 954 963
62. T.M. Penning, and M.C. Byrns Steroid hormone transforming aldo-keto reductases and cancer Ann. NY Acad. Sci. 1155 2009 33 42
63. M.S. Pepper Role of matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis Arterioscler. Thromb. Vasc. Biol. 21 2001 1104 1107
64. F. Raffoul, C. Campla, and M. Nanjundan SnoN/SkiL, a TGFβ signaling mediator: a participant in autophagy induced by arsenic trioxide Autophagy 6 2010 955 957
65. T.L. Rizner, T. Smuc, R. Rupreht, J. Sinkovec, and T.M. Penning AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer Mol. Cell. Endocrinol. 248 2006 126 135
66. K. Shigemasa, X. Tian, L. Gu, H. Tanimoto, L.J. Underwood, T.J. O'Brien, and K. Ohama Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer Oncol. Rep. 11 2004 1153 1159
67. M. Sidiropoulos, G. Pampalakis, G. Sotiropoulou, D. Katsaros, and E.P. Diamandis Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers Tumour Biol. 26 2005 324 336 (Pubitemid 41619463)
68. L. Simson, J.I. Ellyard, and L.A. Dent Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance J. Immunol. 178 2007 4222 4229 (Pubitemid 46492372)
69. D.M. Smith, S. Patel, F. Raffoul, E. Haller, G.B. Mills, and M. Nanjundan Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells Cell Death Differ. 17 2010 1867 1881
70. M.S. Stack, R.D. Gray, and S.V. Pizzo Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain Cancer Res. 53 1993 1998 2004 (Pubitemid 23145717)
71. J. Stulík, K. Koupilova, J. Osterreicher, J. Knízek, A. Macela, J. Bures, P. Jandík, F. Langr, K. Dedic, and P.R. Jungblut Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma Electrophoresis 20 1999 3638 3646 (Pubitemid 30007262)
72. J. Stulík, J. Osterreicher, K. Koupilová, J. Knízek, A. Macela, J. Bures, P. Jandík, F. Langr, K. Dedic, and P.R. Jungblut The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass Electrophoresis 20 1999 1047 1054 (Pubitemid 29222467)
73. L. Sui, Y. Dong, M. Ohno, Y. Watanabe, K. Sugimoto, and M. Tokuda Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors Anticancer Res. 22 2002 3191 3196 (Pubitemid 36070092)
74. H.J. Sung, J.M. Ahn, Y.H. Yoon, T.Y. Rhim, C.S. Park, J.Y. Park, S.Y. Lee, J.W. Kim, and J.Y. Cho Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer J. Proteome Res. 10 2011 1383 1395
75. T. Szarvas, M. Becker, F. vom Dorp, C. Gethmann, M. Tötsch, A. Bánkfalvi, K.W. Schmid, I. Romics, H. Rübben, and S. Ergün Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer Cancer Sci. 101 2010 1300 1308
76. T. Teratani, T. Watanabe, F. Kuwahara, H. Kumagai, S. Kobayashi, U. Aoki, A. Ishikawa, K. Arai, and R. Nozawa Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma Cancer Lett. 175 2002 71 77 (Pubitemid 33153046)
77. R. Uslu, U.A. Sanli, C. Sezgin, B. Karabulut, E. Terzioglu, S.B. Omay, and E. Goker Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines Clin. Cancer Res. 6 2000 4957 4964 (Pubitemid 32110442)
78. Y. Wang, and Y. Sun Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis Curr. Cancer Drug Targets 2 2002 191 207
79. J.S. Wolf, Z. Chen, G. Dong, J.B. Sunwoo, C.C. Bancroft, D.E. Capo, N.T. Yeh, N. Mukaida, and C. Van Waes IL (Interleukin)-1a promotes nuclear factor-kB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas Clin. Cancer Res. 7 2001 1812 1820 (Pubitemid 32708653)
80. Y.F. Wong, T.H. Cheung, K.W. Lo, S.F. Yim, N.S. Siu, S.C. Chan, T.W. Ho, K.W. Wong, M.Y. Yu, V.W. Wang, C. Li, G.J. Gardner, T. Bonome, W.B. Johnson, D.I. Smith, T.K. Chung, and M.J. Birrer Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling Oncogene 26 2007 1971 1982 (Pubitemid 46474633)
81. M. Wysoczynski, K. Miekus, K. Jankowski, J. Wanzeck, S. Bertolone, A. Janowska-Wieczorek, J. Ratajczak, and M.Z. Ratajczak Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas Cancer Res. 67 2007 2131 2140 (Pubitemid 46424232)
82. Y. Yang, M.Z. Dieter, Y. Chen, H.G. Shertzer, D.W. Nebert, and T.P. Dalton Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response J. Biol. Chem. 277 2002 49446 49452 (Pubitemid 36014379)
83. F. Ye, Y. Hu, W. Lu, C. Zhou, and X. Xie Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics Histopathology 53 2008 224 228 (Pubitemid 352032768)
84. Y.C. Yeh, B.S. Sheu, H.C. Cheng, Y.L. Wang, H.B. Yang, and J.J. Wu Elevated serum matrix metalloproteinase-3 and -7 in H. Pylori-related gastric cancer can be biomarkers correlating with a poor survival Dig. Dis. Sci. 55 2010 1649 1657
85. H.Y. Yong, and A. Moon Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells Arch. Pharm. Res. 30 2007 75 81
86. J. Zhang, and B. Wang Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo Gynecol. Oncol. 103 2006 199 206 (Pubitemid 44374690)
87. N. Zhang, Z.M. Wu, E. McGowan, J. Shi, Z.B. Hong, C.W. Ding, P. Xia, and W. Di Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer Cancer Sci. 100 2009 2459 2464